Sara

Sara M. Mariani, MD, MS, PhD Site Editor/Program Director, Medscape Molecular Medicine, Medscape Urology, and Medscape Pharmacists Dr. Mariani has served as research editor at Nature Medicine (New York), after working for 5 years as research scientist at the German Cancer Research Center in Heidelberg, Germany. She completed her clinical training in internal medicine/hematology at the University of Milano and Pavia, Italy, and her doctoral work at New York Medical College. Her research interests included tumor immunology, histocompatibility, immunotherapies, and apoptosis.

72%

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

85%

Examples:

  • The article presents the findings of a study that suggests long COVID could be caused by brain injury without providing any evidence or context for this claim.

Conflicts of Interest

50%

Examples:

  • The article does not disclose any potential conflicts of interest for the authors or the sponsors of the study they cite.

Contradictions

100%

Examples:

  • The article contradicts itself by stating that cognitive deficits in patients who had severe COVID-19 are equivalent to 20 years of brain aging while also implying that these deficits are due to long COVID.

Deceptions

80%

Examples:

  • The article deceptively implies that brain fog is a common complaint among long COVID patients without providing any evidence to support this claim.

Recent Articles

Long COVID: A Complex Phenomenon with Unpredictable Outcomes

Long COVID: A Complex Phenomenon with Unpredictable Outcomes

Broke On: Sunday, 11 February 2024 A recent study in Nature Communications examined the natural history of long COVID in a general population cohort. At six months after infection, 49.5% of subjects had completely recovered while at twelve months, complete recovery was reported by only 49.8%. Partial recovery was achieved by 43.8%, and unrecovered individuals were at 7.4%. The study found that among those with partial or complete recovery at six months, deterioration in recovery status at twelve months was more likely among people with depression while it was less likely among older and most affluent subjects.